Full Text:

 

¿µ³²ÀÇ´ëÇмúÁö Vol.24_No.2 Suppl. P.S1-11, Dec. 2007

Review

ÇϺοä·ÎÁõ»óÀ» º¸À̴ ȯÀڵ鿡¼­ ¾Ç¼ºÁ¾¾çÀÇ Áø´Ü

Diagnosis of Malignant Lesion in Patients with Lower Urinary Tract Symptoms

¹Úµ¿Ãá
¿µ³²´ëÇб³ Àǰú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Ã¥ÀÓÀúÀÚ£º¹Úµ¿Ãá, ´ë±¸±¤¿ª½Ã ³²±¸ ´ë¸í5µ¿ 317-1, ¿µ³²´ëÇб³ Àǰú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Tel: (053) 620-3691, Fax: (053) 627-5535
E-mail: tcpark@med.yu.ac.kr

December 30, 2007

Abstract

Some patients, especially with chronic disease such as diabetes, who suffer from lower urinary tract symptoms (LUTS) just want to take prolonged oral medication (anticholinergics or alpha blockers) without proper evaluation for basic causes. LUTS is commonly occurred by urinary tract infection, several chronic diseases and/or aging itself. However, we should not pass over the fact that LUTS also can be evoked by malignancy. Because there is a higher detection rate of malignancy in patients with microscopic hematuria, urine cytology must be done with ultrasonography, IVP and cystoscopy. In those patients aged over 50 years or high risk group for urothelial carcinoma, it is mandatory to undergo ultrasonography and cystoscopy, even if there is no abnormalities on their urinalysis and urine cytology.

Key Words: Lower urinary tract symptom, Malignancy, Diagnosis

References

1. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 1994 Aug;44(2):153-5.

2. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003 Jan;61(1):37-49.

3. Jacobsen SJ, Girman CJ, Leiber MM. Natural history of benign prostatic hyperplasia. Urology 2001 Dec;58(6):5-16.

4. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol. 1998;33(1):17-21.

5. Massey JA, Abrams PH. Obstructed voiding in the female. Br J Urol. 1988 Jan;61(1):36-9.

6. Lemack GE, Zimmern PE. Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol 2000 Jun;163(6): 1823-8.

7. Carter HB, Allae ME, Partin AW. Diagnosis and staging of prostate cancer. In: Louis RK, Andrew CN, Alan WP, Graig AP, editors. Campbell-Walsh Urology 9th ed. Philadelphia: Saunders; 2007. p. 2971.

8. Messing EM. Urothelial tumor of the bladder. In: Louis RK, Andrew CN, Alan WP, Graig AP, editors. Campbell-Walsh Urology 9th ed. Philadelphia: Saunders; 2007. p. 2418.

9. Potter JM, Quigley AW, Pengelly DP, Fawcett DP, Malone PR. The role of urine cytology in the assessment of lower urinary tract symptoms. Br J urol. 1999 Jul;84(1):30-1.

10. Chang KS. Urinary bladder. In: Richard L, editor. Radiologic illustrated: Uroradiology. 1st ed. Seoul; Saunders; 2003. p. 499.

11. ¹é¼º±Ô, ±èűÔ. Á¤»ó ¼ºÀο¡¼­ÀÇ ¹«Áõ»ó Çö¹Ì°æÀû Ç÷´¢ÀÇ À¯º´À² ¹× Æò°¡. ´ëÇѺñ´¢±â°úÇÐȸÁö 1993 Aug;34(4):642-7.

12. Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screenning by the detection of occult urinary bleeding. J Urol 1992 Sep;148(3):788-90.

13. À̱Ա¤, Àü»óÇö, ¹Ú³ëÁ¤. ¹«Áõ»ó Çö¹Ì°æÀû Ç÷´¢¸¦ º¸ÀÎ ¼ºÀΠȯÀÚÀÇ ÀÓ»óÀû ¼Ò°ß°ú Áø´Ü°Ë»ç ¹æ¹ýÀÇ À¯¿ë¼º. ´ëÇѺñ´¢±â°úÇÐȸÁö 2005 Oct; 46(10):1064-70.

14. Grossheld GD, Carroll PR. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am 1998 Nov;25(4):661-76.

15. Wiener HG, Mian C, Haitel A, Pycha A, Schatzl G, Marberger M. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 1998 Jun;159(6):1876-80.

16. Konety BR, Metro MJ, Melham MF, Salup RR. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract. Urol Int 1999;62(1):26-30.

17. Leyh H, Marberger M, Conort P, Sternberg C, Pansadoro V, Pagano F, et al. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol 1999 Jan;35(1):52-6.

18. Takashi M, Schenck U, Kissel K, Leyh H, Treiber U. Use of diagnostic categories in urinary cytology in comparison with the bladder tumor antigen(BTA) test in bladder cancer patients. Int Urol Nephrol 1999;31(2): 189-96.

19. Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I. Noninvasive detection of bladder cancer with the BTA stat test. J Urol 1999 Feb;161(2):443-6.

20. Dubernald JM, Devonec M, Amiel J, Fontaniere B. Faucon M. Correlation between cytology and cystoscopy in the follow-up of patients with bladder tumours. Eur. Urol 1982;8(1):5-8.

21. Murakami S, Igarashi T, Hara S, Shimazaki J. Strategies for asymptomatic microscopic hematuria : a prospective study of 1034 patients. J Urol 1990 Jul;144(1):99-101.

22. ÃֹαÔ, ±è¿µ¼ö, ±è¼¼Áß. ¹æ±¤¾ÏÀÇ Áø´Ü¿¡ À־ À°¾ÈÀû ȤÀº Çö¹Ì°æÀû Ç÷´¢°¡ BTA Stat °Ë»ç °á°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѺñ´¢±â°úÇÐȸÁö 2001 May;42(5): 489-94.

23. Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988 Nov;169(2):363-5.

24. Aslaksen A, Gadeholt G, Gothlin JH. Ultra- sonography versus intravenous urography in the evaluation of patients with microscopic haematuria. Br J Urol. 1990;66(2):144-7

25. Glen DA, Gilbert FJ, Bayliss AP. Renal carcinomas missed by urography. Br J Urol 1989 May;63(5):457-9.

26. Ellenbogen PH, Scheible FW, Leopold GR. Sensitivity of grey scale ultrasound in detecting urinary tract obstruction. AJR 1978;130:731-3.

27. Corwin HL, Silverstein MD. The diagnosis of neoplasia in patients with asymptomatic microscopic hematuria : a decision analysis. J Urol 1988 May;139(5):1002-6.

28. Á¤½ÂÀÏ, °­Åÿø, ½Å»ó¼ö, ±Çµ¿µæ, ¹Ú±¤¼º, ·ù¼ö¹æ. ¹æ±¤Á¾¾çÀÇ Áø´Ü¿¡¼­ 64ä³Î ´ÙÁß°ËÃâÀü»êÈ­´ÜÃþÃÔ¿µÀ» ÀÌ¿ëÇÑ °¡»ó¹æ±¤°æÀÇ À¯¿ë¼º. ´ëÇѺñ´¢±â°úÇÐȸÁö 2007 Apr;48(3):383-9.

29. È«¼º±Ô, ¾È±Ô¸®, ±èÇöȸ. ¹«Áõ»ó Çö¹Ì°æÀû Ç÷´¢¿¡ ´ëÇÑ ¹æ±¤°æ°Ë»çÀÇ Áø´ÜÀû °¡Ä¡. ´ëÇѺñ´¢±â°úÇÐȸÁö 2000 Jan ;41(1):143-6.

30. Walker L, Liston TG, LLoyd-Davies RW. Does flexible cystoscopy miss more tumours than rod-lens examination? Br J Urol 1993 Oct;72(4):449-50.

31. Hattori R, Ohshima M, Ono Y, Miyake K. The significance of cystoscopy for the diagnosis of urothelial tumors. Int Urol & Nephrol 1993; 25(2):135-9.

32. À̱Ա¤, Àü»óÇö, ¹Ú³ëÁ¤. ¹«Áõ»ó Çö¹Ì°æÀû Ç÷´¢¸¦ º¸ÀÎ ¼ºÀΠȯÀÚÀÇ ÀÓ»óÀû ¼Ò°ß°ú Áø´Ü°Ë»ç ¹æ¹ýÀÇ À¯¿ë¼º ´ëÇѺñ´¢±â°úÇÐȸÁö 2005 Oct;46 (10):1064-70.

33. ÀÌ»óÈÆ, ¼ÛÀ±¼·, ¹Ú¿µÈ£. Midazolam Åõ¿© ¼ö¸éÀ¯¹ß ¹æ±¤°æ°Ë»çÀÇ À¯¿ë¼º°ú ¾ÈÀü¼º. ´ëÇѺñ´¢±â°úÇÐȸÁö 2004 Jun;45(6):557-62.

34. ±è±â½Â, ±èÁÖ¼º, ¹Ú¼º¿î. PropofolÀ» ÀÌ¿ëÇÑ ¼ö¸é ¹æ±¤°æ°Ë»çÀÇ È¿°ú¿Í ¾ÈÁ¤¼º ¿¬±¸. ´ëÇѺñ´¢±â°úÇÐȸÁö 2006 Nov;47(11): 1230-5.

35. Swinn MJ, Walker MM, Harbin LJ, Adshead JM, Witherow RO, Vale JA, et al. Biopsy of the red patch at cystoscopy: is it worthwhile? Eur Urol. 2004 Apr;45(4):471-4.

36. À±Ã¶¿õ, °­Åÿø, ÃÖ Âù, ·ù¼ö¹æ. ¹æ±¤°æ°Ë»ç¿¡¼­ È«¹Ý¼º º´º¯ »ý°ËÀÇ ÀÇÀÇ. ´ëÇѺñ´¢±â°úÇÐȸÁö 2007 May;48(5):489-93.

37. Jichlinski P, Guillou L, Karlsen SJ, Malmstrom PU, Jocham D, Brennhovd B, et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 2003 Jul;170(1):226-9.